|Articles|February 10, 2021
Using Optimized Protocols and Easy Automation to Advance N-Glycan Analysis of Next-Generation Biotherapeutics
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
2
Implications of the First Liquid IV Infliximab Biosimilar
3
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
4
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
5
